The patent on the main ingredient in Ozempic has expired in India, leading to concerns cheap generics may enter the Australian market.
The patent on the main ingredient in Ozempic has expired in India, leading to concerns cheap generics may enter the Australian market.
Doctors warn against pharmacists prescribing medications, but say they should work together.